• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Japan’s stock market emerges as clear winner of Suga’s abrupt resignation

September 7, 2021 by David Barret Leave a Comment

September 7, 2021

By Hideyuki Sano and Tom Westbrook

TOKYO/SINGAPORE (Reuters) – While the race for ruling party leader remains wide open, the Japanese stock market has emerged as a clear winner of Prime Minister Yoshihide Suga’s abrupt departure, with the broad Topix index soaring to 31-year highs.

Suga said on Friday he would not seek reelection at the Liberal Democratic Party (LDP) leadership race this month and would step down, setting the stage for a new premier. Suga’s one-year tenure as prime minister was marred by an unpopular COVID-19 response and dwindling public support.

Since Suga’s shock announcement, the Nikkei has gained almost 4% to its highest level since mid-April while the Topix vaulted nearly 3% to a level not seen since 1990, even though there is no clear front-runner. The LDP’s majority in parliament guarantees the winner will become prime minister.

“Basically his party, the LDP, is market-friendly, but Suga is not well liked due to the handling of the pandemic,” said Dave Wang, a portfolio manager at Nuvest Capital in Singapore.

“With him stepping down, LDP’s chances of winning (lower house elections later this year) go up, and markets are happier.”

As Suga’s departure removes a major source of concern for Japanese markets, market participants say they expect Japanese shares to catch up to other stock markets, given the steady rise in Corporate Japan’s earnings.

(Graphic: Japan earnings recovery – https://ift.tt/38KZBvd)

World stock prices have surged 15% so far this year, reaching record highs, on hopes of a strong global economic recovery from the COVID-19 pandemic, compared with 8% gains in the Nikkei.

Many investors regard vaccine minister Taro Kono and former foreign minister Fumio Kishida as two leading candidates.

Former internal affairs minister Sanae Takaichi could also enjoy a boost after local media reported former Prime Minister Shinzo Abe will be backing her.

“Kono is seen as a reformist and could be positive for stocks while there are some uncertainties on Kishida given his penchant for fiscal tightening. But these views could change depending on the policies they adopt,” said Ryota Sakagami, chief equity strategist at JPMorgan Securities.

Kishida has called for the reduction of income disparities, pledged support to the economically vulnerable, and said an economic stimulus package worth “tens of trillions of yen” was needed to combat the coronavirus.

Kono is thought to focus more on pro-business policies such as deregulation, while Takaichi, a member of the party’s most conservative wing, has said she wants to work towards achieving 2% inflation.

“For the time being, dealing with the coronavirus and economic normalisation would be the top priority for anyone and therefore their policy differences will probably not become evident,” said Sakagami.

Sakagami expected the Topix to rise to 2,100-2,200 by year-end, a 2.9% to 7.8% increase from current levels.

The stock rise also comes as Japan has made progress in vaccine rollouts, with 58% of the population now having received one COVID-19 dose.

“I think stock prices will keep rising. Our vaccination is likely to reach to the top-group levels soon,” said Masaru Ishibashi, joint general manager of trading at Sumitomo Mitsui Bank.

(Reporting by Hideyuki Sano in Tokyo and Tom Westbrook in Singapore; Editing by Ana Nicolaci da Costa)

Source Link Japan’s stock market emerges as clear winner of Suga’s abrupt resignation

David Barret
David Barret

Related posts:

  1. LG B1 OLED price, release date and specs
  2. HPE signs multi-billion dollar NSA computing deal
  3. American Eagle online sales drop on easing COVID-19 curbs, shares slump
  4. Tracking startup focus in the latest Y Combinator cohort

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • US Just Killed NASA’s Mars Sample Return Mission – So What Happens Now?
  • Art Sleuths May Have Recovered Traces Of Da Vinci’s DNA From One Of His Drawings
  • Countries With The Most Narcissists Identified By 45,000-Person Study, And The Results Might Surprise You
  • World’s Oldest Poison Arrows Were Used By Hunters 60,000 Years Ago
  • The Real Reason You Shouldn’t Eat (Most) Raw Cookie Dough
  • Antarctic Scientists Have Just Moved The South Pole – Literally
  • “What We Have Is A Very Good Candidate”: Has The Ancestor Of Homo Sapiens Finally Been Found In Africa?
  • Europe’s Missing Ceratopsian Dinosaurs Have Been Found And They’re Quite Diverse
  • Why Don’t Snorers Wake Themselves Up?
  • Endangered “Northern Native Cat” Captured On Camera For The First Time In 80 Years At Australian Sanctuary
  • Watch 25 Years Of A Supernova Expanding Into Space Squeezed Into This 40-Second NASA Video
  • “Diet Stacking” Trend Could Be Seriously Bad For Your Health
  • Meet The Psychedelic Earth Tiger, A Funky Addition To “10 Species To Watch” In 2026
  • The Weird Mystery Of The “Einstein Desert” In The Hunt For Rogue Planets
  • NASA Astronaut Charles Duke Left A Touching Photograph And Message On The Moon In 1972
  • How Multilingual Are You? This New Language Calculator Lets You Find Out In A Minute
  • Europa’s Seabed Might Be Too Quiet For Life: “The Energy Just Doesn’t Seem To Be There”
  • Amoebae: The Microscopic Health Threat Lurking In Our Water Supplies. Are We Taking Them Seriously?
  • The Last Dogs In Antarctica Were Kicked Out In April 1994 By An International Treaty
  • Interstellar Comet 3I/ATLAS Snapped By NASA’s Europa Mission: “We’re Still Scratching Our Heads About Some Of The Things We’re Seeing”
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2026 · Medical Market Report. All Rights Reserved.

Go to mobile version